Mesoblast Financial Results and Corporate Update Webcast

NEW YORK, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflamm...

Related Keywords

Singapore ,Australia ,China ,Japan ,United States ,Australian ,Paul Hughes ,Steve Dabkowski ,Australian Securities Exchange ,Twitter ,Mesoblast Limited Nasdaq ,Linkedin ,Corporate Communications Investors ,Mesoblast Limited ,